EPCAM and neoplasm: A critical limitation of this approach is its acknowledged inability to effectively enrich and detect CTCs where the expression of target biomarkers such as EpCAM and CK can be significantly lower19, 20, 21, 22, 23 than tumor tissue or reference cell lines.